Impact of Vortioxetine with antiepileptic drugs combined administration on non- convulsive behaviour in kindled rats
DOI:
https://doi.org/10.12775/JEHS.2023.13.03.053Keywords
epilepsy, kindling, depression, non-convulsive behaviour, Vortioxetine, Valproic acid, Phenobarbital, Diphenylhydantoin, pathogenetic correctionAbstract
Epilepsy is a prolonged, progressively advancing nervous and psychiatric disorder of various etiologies, characterized by paroxysmal and relatively persistent psychological disturbances. A significant burden of comorbid pathology is attributed to psychiatric disorders. Depressive disorders are among the most common behavioral comorbidities in patients with epilepsy, often remaining undiagnosed and untreated. The approach to treating depression in epilepsy patients is currently underdeveloped. To fully understand the prospects of the experimental framework for minimizing and/or eliminating depressive behavioral manifestations during the interictal period under conditions of chronic epileptogenesis, we conducted a series of studies to determine the effectiveness of comprehensive correction of non-seizure behavior in kindling animals. The aim of this study is to delineate alterations in the expression of non-seizure behavior in rats due to the combined administration of Vortioxetine with antiepileptic drugs in the dynamic context of chronic kindling-induced seizure activity. It has been established that in rats during the development of Picrotoxin-induced chronic epileptic syndrome, disruptions in late-tonic, emotional, and swimming types of behavior are observed, which are manifestations of non-seizure behavior. It has been proven that the combined administration of Valproic acid and Vortioxetine results in successful correction of the tested forms of behavior. Less effectiveness is observed with vortioxetine alone, and the least effectiveness is noted in a smaller number of investigated behavior types after valproic acid administration. The data demonstrate balancing systemic-antisynergistic relationships, the imbalance of which during the development of picrotoxin-induced chronic epileptic syndrome allows the development of non-seizure behavior forms during interictal periods. The obtained data and their analysis provide experimental groundwork for the appropriateness of clinically testing the combined administration of Vortioxetine with Valproic acid as part of complex therapy in epilepsy patients with the presence of a depressive behavioral component.
References
Vastyanov R.S. Pathophysiological mechanisms of epileptic activity in chronic epilepsy (experimental study). Abstr. Doctor of Science degree. Speciality. 14.03.04 “Pathological physiology”. Odesa. 2013: 35 [In Ukrainian].
Vastyanov R.S., Oliynyk A.A., Kashchenko O.A. Changes in the behavior of rats during swimming with pilocarpine convulsions. Odesa Medical Journal. 2002; 6: 11-15 [In Ukrainian].
Vastyanov R.S., Kopyova N.V. Peculiarities of the emotional behavior of rats in the dynamics of the development of pilocarpine-induced spontaneous seizures. Ukrainian medical almanac. 2009; 12(1): 28–33 [In Ukrainian].
Ostapenko I.O. The effect of brintellix on the expressiveness of memory and learning processes under conditions of chronic convulsive syndrome. Herald of marine medicine. 2022; 2(95): 38-51 [In Ukrainian].
Prishchepa E.A. Changes in motor, exploratory activity and emotional behavior of animals under conditions of long-term chemical kindling. Herald of psychiatry and psychopharmacotherapy. 2012; 2: 30-38 [In Russian].
Shagiakhmetov F.Sh., Anokhin P.K., Shamakina I.Yu. Vortioxetine: Mechanisms of Multimodality and Clinical Efficacy. Social and Clinical Psychiatry. 2016; 26(4): 84-96 [In Russian].
Shandra A.A., Godlevsky L.S., Mazarati A.M. Kindling as a model for the formation of behavioral disorders. Uspekhi Fiziol. Sciences. 1990; 21 (4): 50-68 [In Russian].
Shandra A.A., Godlevsky L.S., Mazarati A.M. Formation of motor programs during pharmacological kindling. I.M. Sechenov Fiziol. J. USSR. 1990; 76(10): 1384-1392 [In Russian].
Shandra A.A., Godlevsky L.S., Brusentsov A.I. Kindling and epileptic activity. Odessa : Astroprint. 1999: 191 [In Russian].
Akanuma N., Hara E., Adachi N., Hara K., Koutroumanidis M. Psychiatric comorbidity in adult patients with idiopathic generalized epilepsy. Epilepsy Behav. 2008; 13(1): 248–251.
Anhoury S., Brown R.J., Krishnamoorthy E.S., Trimble M.R. Psychiatric outcome after temporal lobectomy: a predictive study. Epilepsia. 2000; 41: 1608-1615.
Aycicek A., Iscan A. The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children. Eur. Neurol. 2007; 57(2): 65–69.
Barry J.J., Lembke A., Huynh N. Affective disorders in epilepsy. Psychiatric Issues in Epilepsy: A Practical Guide to Diagnosis and Treatment. Ed. by Ettinger A., Kanner A. Philadelphia: Lippincott/Williams and Wilkins. 2001: 45-71.
Cardamone L., Salzberg M.R., O'Brien T.J., Jones N.C. Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder? Br J Pharmacol. 2013; 168(7): 1531–1554.
Claycomb R.J., Hewett S.J., Hewett J.A. Prophylactic, prandial rofecoxib treatment lacks efficacy against acute PTZ-induced seizure generation and kindling acquisition. Epilepsia. 2011; 52(2): 273–283.
Dudra-Jastrzebska M., Andres-Mach M.M., Luszczki J.J., Czuczwar S.J. Mood disorders in patients with epilepsy. Pharmacol. Rep. 2007; 59: 369–378.
Ettinger A.B., Weisbrot D.M., Nolan E.E., Gadow K.D., Vitale S.A., Andriola M.R., Lenn N.J., Novak G.P., Hermann B.P. Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia. 1998; 39: 595-599.
Frucht M.M., Quigg M., Schwaner C., Fountain N.B. Distribution of seizure precipitants among epilepsy syndromes. Epilepsia. 2000; 41: 1534-1539.
Hamid H., Kanner A.M. Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs? Epilepsy Behav. 2013; 26(3): 261-265.
Jones J.E., Hermann B.P., Barry J.J., Gilliam F.G., Kanner A.M., Meador K.J. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav. 2003; 4(3): 31–38.
Kanner A.M. The treatment of depressive disorders in epilepsy: what all neurologists should know. Epilepsia. 2013; 54: 3–12.
La France W.C. Jr, Kanner A.M., Hermann B. Psychiatric comorbidities in epilepsy. Neurobiology. 2008; 83: 347–383.
Maguire M.J., Marson A.G., Nevitt S.J. Antidepressants for people with epilepsy and depression. Cochrane Database Syst Rev. 2021; 4(4): CD010682. doi: 10.1002/14651858.CD010682.pub3.
Myslobodsky M., Kofman O., Mintz M. Convulsant specific architecture of postictal behavioral syndrome in the rat. Epilepsia. 1981; 27(4): 559–568.
Nestler E.J., Barrot M., Di Leone R.J., Eisch A.J., Gold S.J, Monteggia L.M. Neurobiology of depression. Neuron. 2002; 34(1): 13–25.
Ostapenko I.O. The perspectives of pharmacological correction of depressive disorders and cognitive deficit as post-traumatic epilepsy leading syndromes. Journal of Education, Health and Sport. 2022; 12(2): 360-369.
Post R.M., Squillace K.M., Pert A., Sass W. The effect of amygdala kindling on spontaneous and cocaine-induced motor activity and lidocaine seizures. Psychopharmacology (Berl). 1981; 72(2): 189-196.
Pressler R.M., Lagae L. Why we urgently need improved seizure and epilepsy therapies for children and neonates. Neuropharmacology. 2020; 170: 107854. doi: 10.1016/j.neuropharm.2019.107854.
Riga M.S., Sánchez C., Celada P., Artigas F. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission. Neuropharmacology. 2016; 108: 73–81.
Shandra A.A., Mazarati A.M., Godlevsky L.S., Vastyanov R.S. Chemical Kindling: Implications for Antiepileptic Drugs-Sensitive and Resistant Epilеpsy Model. Epilepsia. 1996; 37(3): 269-274.
Shandra A.A., Godlevsky L.S., Vastyanov R.S. Epileptic and antiepileptic systems interrelation as the systemic indicator of the complexity of epileptic activity manifestation. Pan-Brain Abnormal Neural Network in Epilepsy. Ed. by Feng Ru Tang. Singapore : Research Signpost, 2009. 99-120.
Stenkrona P., Halldin C., Lundberg J. 5-HTT and 5-HT1A receptor occupancy of the novel substance vortioxetine (Lu AA21004).A PET study in control subjects. Eur. Neuropsychopharmacol. 2013; 23: 1190–1198.
Thijs R.D., Surges R., O'Brien T.J., Sander J.W. Epilepsy in adults. Lancet. 2019; 393(10172): 689-701.
Thapar А., Kerr M., Harold G. Stress, anxiety, depression, and epilepsy: Investigating the relationship between psychological factors and seizures. Epilepsy Behav. 2009; 14: 134–140.
Vastyanov R.S., Stoyanov O.M., Platonova O.M., Yermuraki P.P., Ostapenko I.O., Tatarko S.V., Bibikova V.M. Pathogenetic mechanisms of convulsive depressive syndrome in conditions of kindling model of epileptogenesis. World of medicine and biology. 2021; 1(75): 181-186.
Vastyanov R.S., Kirchev V.V., Muratova T.M., Kashchenko O.A., Vastyanova O.V., Tatarko S.V., Zayats L.M. Comparative analysis of motor and emotional behavioral disorders in conditions of experimental chronic ischemic and chronic convulsive syndromes. World of medicine and biology. 2021; 2(76): 183-188.
Vrijmoed-de Vries M.C., Cools A.R. Differential effects of striatal injections of dopaminergic, cholinergic and GABAergic drugs upon swimming behavior of rats. Brain Res. 1986; 364(1): 77-90.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 I. Ostapenko
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 205
Number of citations: 0
